MedTrace Logo

Stem Cell Therapy for Patients With Focal Segmental Glomerulosclerosis

NCT02693366 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2020-01-28

No results posted yet for this study

Summary

The purpose of this study is to analyze the safety, renal function, metabolic disorders and quality of life data in patients with focal segmental glomerulosclerosis treated with endovascular infusion of bone marrow derived mononuclear cells.

Conditions

  • Focal Segmental Glomerulosclerosis
  • Chronic Kidney Diseases

Interventions

OTHER

Bone marrow stem cell

Endovascular infusion of bone marrow derived cells in both renal arteries.

Sponsors & Collaborators

  • Ministry of Science and Technology, Brazil

    collaborator OTHER

  • Ministry of Health, Brazil

    collaborator OTHER_GOV

  • National Research Council, Brazil

    collaborator OTHER

  • Rio de Janeiro State Research Supporting Foundation (FAPERJ)

    collaborator OTHER_GOV

  • Universidade Federal do Rio de Janeiro

    lead OTHER

Principal Investigators

  • Marcelo Marcos Morales, MD,PHD · Universidade Federal do Rio de Janeiro

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-25
Primary Completion
2018-02-28
Completion
2018-05-16

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02693366 on ClinicalTrials.gov